Isbn: 9786139430871 - the role of her2 gene mutation in transitional cell carcinoma: of urinary bladder using cish method (5 risultati)

Perfeziona la tua ricerca

  • Libri (5)

  • Nuovo (5)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: Noor Publishing, 2019

    6139430879 / 9786139430871

    • Brossura

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 28,70

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. The role of HER2 Gene Mutation in Transitional Cell Carcinoma | of urinary bladder Using CISH Method | Ammar Eesa Mahdi | Taschenbuch | 152 S. | Englisch | 2019 | Noor Publishing | EAN 9786139430871 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

  • Lingua: Inglese

    Editore: Noor Publishing Jul 2019, 2019

    6139430879 / 9786139430871

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 31,90

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The urinary bladder cancer (UBC ) are most common type of cancer of the urinary tract. It is regarded as the second and the fourth most common cancer types for males in Iraq and in the United State of America (USA) respectively and as tenth and eleventh most common cancer types for females in both Iraq and USA respectively. HER2/neu protein is glycoprotein produced by HER2 gene which lies in 17q21 (long arm of chromosome 17). This glycoprotein is normally found in lung, breast, urinary bladder, prostate and stomach, and its cytoplasmic portion has enzymatic function (tyrosine kinase activity). This receptor is responsible for the cell survival, normal cell growing and inhibition of apoptosis. HER2/neu protein overexpression is measured by IHC, but when the result of IHC is equivocal to HER2/neu protein (+ 2), Then, HER2 gene amplification is measured by using an accurate and more practical CISH method Several clinical trials are currently investigating the benefit of HER2-targeted therapy in urothelial bladder cancer. Patients with HER2 amplified UBC could potentially profit from these therapies. 152 pp. Englisch.

  • Lingua: Inglese

    Editore: Noor Publishing, 2019

    6139430879 / 9786139430871

    • Brossura
    • Print on Demand

    Da: moluna, Greven, Germaniamoluna

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 28,29

    EUR 48,99 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mahdi Ammar EesaAmmar Eesa Mahdi, Assi. lecturer at the University of Babylon, Faculty of Dentistry and graduated from the Faculty of Medicine, University of Babylon in 2005 and then got a master s degree in Histopathology from the F.

  • Lingua: Inglese

    Editore: Noor Publishing, 2019

    6139430879 / 9786139430871

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 47,67

    EUR 30,50 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The urinary bladder cancer (UBC ) are most common type of cancer of the urinary tract. It is regarded as the second and the fourth most common cancer types for males in Iraq and in the United State of America (USA) respectively and as tenth and eleventh most common cancer types for females in both Iraq and USA respectively. HER2/neu protein is glycoprotein produced by HER2 gene which lies in 17q21 (long arm of chromosome 17). This glycoprotein is normally found in lung, breast, urinary bladder, prostate and stomach, and its cytoplasmic portion has enzymatic function (tyrosine kinase activity). This receptor is responsible for the cell survival, normal cell growing and inhibition of apoptosis. HER2/neu protein overexpression is measured by IHC, but when the result of IHC is equivocal to HER2/neu protein (+ 2), Then, HER2 gene amplification is measured by using an accurate and more practical CISH method Several clinical trials are currently investigating the benefit of HER2-targeted therapy in urothelial bladder cancer. Patients with HER2 amplified UBC could potentially profit from these therapies.

  • Lingua: Inglese

    Editore: Noor Publishing Jul 2019, 2019

    6139430879 / 9786139430871

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 31,90

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The urinary bladder cancer (UBC ) are most common type of cancer of the urinary tract. It is regarded as the second and the fourth most common cancer types for males in Iraq and in the United State of America (USA) respectively and as tenth and eleventh most common cancer types for females in both Iraq and USA respectively. HER2/neu protein is glycoprotein produced by HER2 gene which lies in 17q21 (long arm of chromosome 17). This glycoprotein is normally found in lung, breast, urinary bladder, prostate and stomach, and its cytoplasmic portion has enzymatic function (tyrosine kinase activity). This receptor is responsible for the cell survival, normal cell growing and inhibition of apoptosis. HER2/neu protein overexpression is measured by IHC, but when the result of IHC is equivocal to HER2/neu protein (+ 2), Then, HER2 gene amplification is measured by using an accurate and more practical CISH method Several clinical trials are currently investigating the benefit of HER2-targeted therapy in urothelial bladder cancer. Patients with HER2 amplified UBC could potentially profit from these therapies.Books on Demand GmbH, Überseering 33, 22297 Hamburg 152 pp. Englisch.